METHODS: One hundred thirty-seven patients with GBCC (T1-T4) were prospectively recruited between May 2020 and June 2022 with the intent to evaluate the incidence of PV-FN metastases and clinicopathological factors predicting them.
RESULTS: PV-FN metastases were seen in 26 patients (18.9%; 26/137). The occult metastasis rate was 8.7% (12/137). On multivariate analysis, pathological T4 stage (pT4), LVE positivity, and intermediate-high BGS were statistically significant predictors of PV-FN metastases in our study.
CONCLUSIONS: Incidence of PV-FN metastasis is high (18.9%) in GBCC, which can be potentially the first sentinel station in the lymphatic drainage pattern for this sub-site. Meticulous clearance of this nodal basin is of paramount importance during neck dissection to prevent nodal recurrences.
METHODS: Level 2 (CEBM-Level of Evidence-2.1) Laryngoscope, 2024.
方法:2020年5月至2022年6月,前瞻性招募了137例GBCC(T1-T4)患者,旨在评估PV-FN转移的发生率和预测其临床病理因素。
结果:在26例患者中发现了PV-FN转移(18.9%;26/137)。隐匿性转移率为8.7%(12/137)。在多变量分析中,病理T4分期(pT4),LVE积极性,在我们的研究中,中高BGS是PV-FN转移的统计学显著预测因子。
结论:GBCC中PV-FN转移的发生率很高(18.9%),这可能是该子站点淋巴引流模式中的第一个前哨站。在颈淋巴结清扫术中,要防止淋巴结复发,必须仔细清除该淋巴结盆地。
方法:2级(CEBM-证据级别-2.1)喉镜,2024.